These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 4729848

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Prophylactic procainamide.
    Yarnall SR.
    N Engl J Med; 1970 Mar 05; 282(10):568-9. PubMed ID: 5413109
    [No Abstract] [Full Text] [Related]

  • 4. Antiarrhythmic prophylaxis with procainamide in acute myocardial infarction.
    Koch-Weser J, Klein SW, Foo-Canto LL, Kastor JA, DeSanctis RW.
    N Engl J Med; 1969 Dec 04; 281(23):1253-60. PubMed ID: 4900236
    [No Abstract] [Full Text] [Related]

  • 5. Proceedings: Comparison of mexiletine and procainamide in prevention of recurrent ventricular arrhythmias after acute myocardial infarction.
    Campbell RW, Talbot RG, Dolder M, Prescott L, Julian DG.
    Br Heart J; 1975 Jul 04; 37(7):779. PubMed ID: 1156488
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Procainamide in plasma following administration of sustained-release tablets in acute myocardial infarction.
    Ihlen H, Skomedal T, Stafsnes H, Ditlefsen EM.
    Curr Ther Res Clin Exp; 1975 Mar 04; 17(3):257-62. PubMed ID: 805020
    [No Abstract] [Full Text] [Related]

  • 9. Long-term use of procaine amide following acute myocardial infarction.
    Kosowsky BD, Taylor J, Lown B, Ritchie RF.
    Circulation; 1973 Jun 04; 47(6):1204-10. PubMed ID: 4122729
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prophylactic procainamide.
    Bete JM.
    N Engl J Med; 1970 Mar 05; 282(10):569. PubMed ID: 5413111
    [No Abstract] [Full Text] [Related]

  • 12. Prophylactic procainamide.
    Koch-Weser J.
    N Engl J Med; 1970 Mar 05; 282(10):569-70. PubMed ID: 5413112
    [No Abstract] [Full Text] [Related]

  • 13. Dysrhythmia prophylaxis.
    Killip T.
    N Engl J Med; 1969 Dec 04; 281(23):1304-5. PubMed ID: 5349809
    [No Abstract] [Full Text] [Related]

  • 14. [Serum concentrations of procainamide during treatment with ordinary and sustained-release tablets].
    Henningsen P, Laursen HB, Christiansen BD, Moller J.
    Ugeskr Laeger; 1976 Sep 27; 138(40):2433-7. PubMed ID: 968997
    [No Abstract] [Full Text] [Related]

  • 15. Clinical application of the pharmacokinetics of procaine amide.
    Koch-Weser J.
    Cardiovasc Clin; 1974 Sep 27; 6(2):63-75. PubMed ID: 4613464
    [No Abstract] [Full Text] [Related]

  • 16. [Oral administration of procainamide for ventricular arrhythmia. Plasma concentrations during use of tablets(Pronestyl) and a slow-release preparation (Porcainamide Durettes)].
    Bliddal J.
    Ugeskr Laeger; 1976 Sep 27; 138(40):2425-33. PubMed ID: 968996
    [No Abstract] [Full Text] [Related]

  • 17. Arrhythmia prophylaxis with procaine amide: plasma concentrations in relation to dose.
    Collste P, Karlsson E.
    Acta Med Scand; 1973 Nov 27; 194(5):405-11. PubMed ID: 4757219
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Prevention of rhythm disorders in acute myocardial infarct].
    Djordjevic BS, Bozinovic L.
    Actual Cardiol Angeiol Int (Paris); 1966 Nov 27; 15(2):109-11. PubMed ID: 5927070
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.